SCHEMBL4415077

SCHEMBL4415077

Cc1ccc(NC(=O)c2cc(CN(C)C)cc(C(C)(C)C)c2)cc1-c1cc(C(=O)NCC(C)(C)C)on1

nearest known ligand 0.52

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 18/20 0.52
BRAF P15056 18/20 0.52
ABL1 P00519 1/20 0.38
CSF1R P07333 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5593338 0.91 RAF1 (0.44) RAF1BRAFCSF1R
SCHEMBL4413443 0.89 RAF1 (0.41) RAF1BRAF
SCHEMBL4552227 0.88 RAF1 (0.44) RAF1BRAF
SCHEMBL4410934 0.88 RAF1 (0.44) RAF1BRAF
SCHEMBL4408574 0.87 RAF1 (0.44) RAF1BRAF
SCHEMBL4411086 0.87 NR1H4 (0.46) RAF1BRAF
SCHEMBL4565782 0.86 BRAF (0.43) RAF1BRAF
SCHEMBL4410316 0.86 RAF1 (0.43) RAF1BRAF
SCHEMBL4417623 0.85 TEK (0.51) RAF1BRAFCSF1R
SCHEMBL4565727 0.85 NR1H4 (0.48) RAF1BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035005-A2 THERAPY USING CYTOKINE INHIBITORS Kemia, INC. (US) 2009-03-18 EP disclosed
WO-2007146712-A2 THERAPY USING CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-12-21 WO disclosed